Candel Therapeutics CADL reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Candel Therapeutics missed estimated earnings by 52.63%, reporting an EPS of $-0.29 versus an estimate of $-0.19.
Revenue was down $31 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 8.49% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Candel Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.